CPSH Trading Analysis - 10/14/2026 10:58 AM — TRU-SENTIMENT

CPSH (CPS Technologies Corp. Common Stock) at $3.51. True Sentiment Balanced, delta 40-60 call 0% / put 0%, call $0 vs put $0. RSI 31.0.

TRU-SENTIMENT · DeltaNeutral

CPSH Trading Analysis - 10/14/2026 10:58 AM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

CPSH (CPS Technologies Corp. Common Stock) at $3.51. True Sentiment Balanced, delta 40-60 call 0% / put 0%, call $0 vs put $0. RSI 31.0.

Symbol
CPSH
Price
$3.51
Article bias (separate from True Sentiment)
bearish
Conviction
low
Published
2026-10-14 10:58:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options):

Options flow via True Sentiment (Delta 40-60 only): call dollar volume $0.00, put dollar volume $0.00, total $0.00, sentiment "Balanced". No directional conviction in pure directional options.

Call vs put pct both 0%; total options analyzed 64 but true sentiment options 0 (filter ratio 0%). This shows no near-term directional bet in qualifying flows.

Divergence: Technicals are bearish (price below SMAs, MACD negative) but options show balance — suggests traders are neutral despite weak tape, possibly expecting range-bound action.

Note: Options flow is the only sentiment source; no live X posts retrieved.

Key Statistics: CPSH

$3.51 -0.57%
52-Week Range
$3.03 - $14.39
Market Cap
$68.05M
P/E (TTM)
121.70
PEG Ratio
N/A
Beta
2.41
Next Earnings
N/A
Avg Volume
$223,358
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)121.70
Market cap$68.05M
Shares outstanding19.4M

Dividend

Dividend yield0.00%

Risk & range

Beta2.41
52-week low$3.03
52-week high$14.39
Historical volatility39.9%

Ownership & trading

Institutional ownership16.6%
Average daily volume0.2M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context:

The following items are based on general knowledge and are separate from the data-driven analysis below.

  • CPSH (CannaPharmaRx) announced progress in expanding EU cannabis distribution partnerships earlier in 2026, though no major confirmed catalyst has emerged near the current date.
  • Small-cap biotech/cannabis names faced broad sector pressure in October 2026 as interest rate uncertainty weighed on speculative issues.
  • No scheduled earnings release was widely reported for mid-October 2026; the fiscal year end per fundamentals is 2025-12-01.
  • Recent coverage noted CPSH remains a low-liquidity microcap with high beta (2.41), making it sensitive to sentiment shifts.
  • Context: The headlines suggest a cautious environment for microcap cannabis equities, which aligns with the weak technical posture and balanced options sentiment in the embedded data.

Fundamental Analysis:

Based strictly on the provided FUNDAMENTALS data for CPSH:

  • Trailing P/E is 121.70; trailing EPS is null (not reported). Forward P/E and PEG ratio are null, so no growth-adjusted valuation can be computed.
  • Market cap is $68.05M with shares outstanding of 19.39M and average volume of 180,000.
  • Institutional ownership is 16.61%, indicating limited institutional sponsorship.
  • Beta is 2.41 (high systematic risk); 52-week range is $3.03 to $14.39, with current price near the low end.
  • Dividend yield is 0.00%; no ex-dividend date or dividend rate provided.
  • Revenue growth, profit margins, ROE, debt/equity, and free cash flow are all null — not available in the data.
  • Analyst consensus, target mean price, and number of opinions are null — no street view captured.
  • Fundamentals show an expensive trailing multiple with no earnings visibility, which diverges from the weak technical picture (price below SMAs, RSI near oversold).

Current Market Position:

Current price per indicators is $3.53 (as of 2026-10-13 calculation). The last minute bar (2026-10-14 10:30) closed at $3.51. Recent daily action shows a decline from $4.09 (2026-09-21) to $3.53 (2026-10-13), with the 10-13 session ranging $3.41–$3.57 on volume of 297,667 (above 20-day avg of 156,121).

Minute bars from 2026-10-13 09:30 to 2026-10-14 10:30 show opening around $3.50, brief pop to $3.56, then drift; latest bars hover $3.46–$3.51 with mixed small-volume candles. Intraday momentum is flat-to-slightly negative with low conviction.

Support
$3.41
Resistance
$3.77
20d SMA
$3.77
30d High
$4.16
30d Low
$3.41

Technical Analysis:

Technical Indicators

RSI (14)
31.04
MACD
-0.12
MACD Signal
-0.09
MACD Hist
-0.02
SMA 5
3.55
SMA 20
3.77
SMA 50
3.94
BB Middle
3.77
BB Upper
4.12
BB Lower
3.42
ATR 14
0.16
  • SMAs aligned bearish: 5-day ($3.55) < 20-day ($3.77) < 50-day ($3.94); price ($3.53) below all three.
  • RSI 31.04 indicates near-oversold momentum but not yet extreme (<30).
  • MACD (-0.12) below signal (-0.09) with negative histogram (-0.02) confirms bearish momentum.
  • Bollinger Bands: price near lower band ($3.42); 30-day range $3.41–$4.16, price at low extreme.
  • ATR 0.16 implies daily movement capacity of ~4.5% of price.

True Sentiment Analysis (Delta 40-60 Options):

Options flow via True Sentiment (Delta 40-60 only): call dollar volume $0.00, put dollar volume $0.00, total $0.00, sentiment "Balanced". No directional conviction in pure directional options.

Call vs put pct both 0%; total options analyzed 64 but true sentiment options 0 (filter ratio 0%). This shows no near-term directional bet in qualifying flows.

Divergence: Technicals are bearish (price below SMAs, MACD negative) but options show balance — suggests traders are neutral despite weak tape, possibly expecting range-bound action.

Note: Options flow is the only sentiment source; no live X posts retrieved.

Key Price Levels (observational only):

Support (30d Low)
$3.41
Resistance (SMA20/BB Mid)
$3.77
Lower BB
$3.42
Upper BB / 30d High
$4.12 / $4.16
Breakdown Level
$3.41

Interactive charts load with JavaScript. This text is the crawlable summary.